Cargando…

The Role of Diet and Interventions on Multiple Sclerosis: A Review

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by inflammation and neurodegeneration. The most prominent clinical features include visual loss and sensorimotor symptoms and mainly affects those of young age. Some of the factors affecting its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stoiloudis, Panagiotis, Kesidou, Evangelia, Bakirtzis, Christos, Sintila, Styliani-Aggeliki, Konstantinidou, Natalia, Boziki, Marina, Grigoriadis, Nikolaos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955724/ https://www.ncbi.nlm.nih.gov/pubmed/35334810 http://dx.doi.org/10.3390/nu14061150

Ejemplares similares

CNS Ageing in Health and Neurodegenerative Disorders
por: Kesidou, Evangelia, et al.
Publicado: (2023)

Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response
por: Boziki, Marina, et al.
Publicado: (2022)

Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center
por: Boziki, Marina, et al.
Publicado: (2021)

Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor Prognosis
por: Boziki, Marina, et al.
Publicado: (2022)

COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Biomarkers in Rare Demyelinating Disease of the Central Nervous System
por: Boziki, Marina, et al.
Publicado: (2020)

A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination
por: Boziki, Marina, et al.
Publicado: (2021)

The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics
por: Barmpagiannos, Konstantinos, et al.
Publicado: (2023)

The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases
por: Sintila, Styliani-Aggeliki, et al.
Publicado: (2023)

Optical Coherence Tomography and Optical Coherence Tomography with Angiography in Multiple Sclerosis
por: Chalkias, Ioannis-Nikolaos, et al.
Publicado: (2022)

Prevention, Intervention and Care of Neurodegenerative Diseases
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Smell as a Disease Marker in Multiple Sclerosis
por: Printza, Athanasia, et al.
Publicado: (2022)

The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database
por: Bakirtzis, Christos, et al.
Publicado: (2020)

Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction
por: Boziki, Marina, et al.
Publicado: (2023)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

A Greek Validation Study of the Multiple Sclerosis Work Difficulties Questionnaire-23
por: Bakirtzis, Christos, et al.
Publicado: (2021)

The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians
por: Bakirtzis, Christos, et al.
Publicado: (2018)

Estimating Everyday Neuropsychological Functioning in Multiple Sclerosis: Reliability and Validity of the Greek Multiple Sclerosis Neuropsychological Questionnaire
por: Konstantinopoulou, Eleni, et al.
Publicado: (2018)

Lumbar spine intrathecal transplantation of neural precursor cells promotes oligodendrocyte proliferation in hot spots of chronic demyelination
por: Theotokis, Paschalis, et al.
Publicado: (2021)

Application of antibody phage display to identify potential antigenic neural precursor cell proteins
por: Paspaltsis, Ioannis, et al.
Publicado: (2020)

Developmental Cues and Molecular Drivers in Myelinogenesis: Revisiting Early Life to Re-Evaluate the Integrity of CNS Myelin
por: Dermitzakis, Iasonas, et al.
Publicado: (2022)

Spatio-temporal expression profile of NGF and the two-receptor system, TrkA and p75NTR, in experimental autoimmune encephalomyelitis
por: Delivanoglou, Nickoleta, et al.
Publicado: (2020)

Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial
por: Messinis, Lambros, et al.
Publicado: (2017)

Humoral response in experimental autoimmune encephalomyelitis targets neural precursor cells in the central nervous system of naive rodents
por: Kesidou, Evangelia, et al.
Publicado: (2017)

COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Signaling through the S1P−S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment
por: Chatzikonstantinou, Simela, et al.
Publicado: (2021)

Multiple Sclerosis: Shall We Target CD33?
por: Siokas, Vasileios, et al.
Publicado: (2020)

Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study
por: Pantzaris, Marios C, et al.
Publicado: (2022)

Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options
por: Andravizou, Athina, et al.
Publicado: (2019)

Virus-mediated autoimmunity in Multiple Sclerosis
por: Grigoriadis, Nikolaos, et al.
Publicado: (2006)

Editorial: Complement in nervous system disease
por: Michailidou, Iliana, et al.
Publicado: (2023)

Relationship between Helicobacter pylori infection and multiple sclerosis
por: Gavalas, Emmanuel, et al.
Publicado: (2015)

Therapeutic Benefits of Short-Arm Human Centrifugation in Multiple Sclerosis–A New Approach
por: Kourtidou-Papadeli, Chrysoula, et al.
Publicado: (2022)

Origin and Emergence of Microglia in the CNS—An Interesting (Hi)story of an Eccentric Cell
por: Dermitzakis, Iasonas, et al.
Publicado: (2023)

Oxidative Stress and Neurodegeneration: Interconnected Processes in PolyQ Diseases
por: Gkekas, Ioannis, et al.
Publicado: (2021)

Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination
por: Theotokis, Paschalis, et al.
Publicado: (2016)

Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation
por: Mouzaki, Athanasia, et al.
Publicado: (2015)

Correction: Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation
por: Mouzaki, Athanasia, et al.
Publicado: (2016)

Speech deficits in multiple sclerosis: a narrative review of the existing literature
por: Plotas, Panagiotis, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a9aefrvsmav5ismrpuc120o5fi